CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 48 enrolled
Drug / intervention
dydrogesterone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02262481
NCT02262481N/ACompleted
CompareCT.gov

A Randomized, Double Blinded, Placebo Controlled Trial of Oral Progestogen Supplementation in the Prevention of Recurrent Uterine Contraction in Preterm Labor

Chulalongkorn University·interventional·Posted Oct 13, 2014·Updated Jan 28, 2016

In Brief

A clinical study evaluating dydrogesterone and placebo for Preterm Labor. Completed, enrolled 48 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the effect of oral progesterone supplementation in preterm labor on the prevention of recurrent uterine contraction and prolonging pregnancy period, and its side effect.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPreterm Labor
CountriesThailand
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 13, 2014
Enrollment StartAug 1, 2014
Primary CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 11.7 years ago

Interventions

dydrogesteronedrug

placebodrug